Bristol-Myers Surrenders Anti-HIV Drug Patent In Thailand
Bristol-Myers Squibb has given up a long-standing patent dispute with Thai AIDS activists and agreed to surrender its patent for the anti-retroviral drug didanosine (ddI) in tablet form....To view the full article, register now.
Already a subscriber? Click here to view full article